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Abstract 
Background: Tianma‑Gouteng‑Yin (TGY), which is common Chinese medicine formulation consisting of 11 different 
herbs and being used in China for the treatment of Parkinson’s disease, inflammatory conditions and cardiovascular 
diseases, was selected for full component analysis. The aim of this study was to quantitatively analyze the chemical 
profiles of ten commercial TGY samples and one sample produced in our laboratory.
Methods: Ultra‑high performance liquid chromatography (UHPLC) coupled with quadrupole‑tandem time‑of‑flight 
mass spectrometry (Q‑TOF‑MS) was used to analyze the non‑saccharide small molecule components of the different 
TGY samples. The established method was validated in terms of its linearity, sensitivity, precision, accuracy and stabil‑
ity. High performance liquid chromatography coupled with evaporative light scattering detection (HPLC‑ELSD) was 
also used to quantify three major saccharides (fructose, glucose and sucrose).
Results: The relative standard deviations for the precision, repeatability and stability of these compounds were less 
than 5 %, while the accuracy of the method was 95–105 %. Twenty‑eight of the compounds found in TGY were suc‑
cessfully identified, with 20 being quantified. The macromolecules present in these samples were also identified using 
an ethanol precipitation method, representing 294.68–696.64 mg/g of the total material depending on the batch. 
Notably, the components identified using this method represented up to 78 % of the total weight of the TGY samples.
Conclusions: The developed UHPLC/Q‑TOF‑MS and HPLC‑ELSD methods successfully identified 28 of the complex 
compounds found in TGY.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Tianma-Gouteng-Yin (TGY) is commonly used in Chi-
nese medicine for calming liver wind, clearing heat, pro-
moting blood flow and nourishing the liver and kidney 
[1]. Several clinical studies [2–4, 12] showed that TGY 
can reduce the motor fluctuations of Parkinson’s disease 
(PD) patients. Pharmacological studies showed that TGY 
can prevent the apoptosis of dopaminergic neurons [2]. 
Furthermore, some of the active compounds isolated 
from the constituent of TGY exhibit neuroprotective, 
anti-inflammatory and cardiovascular protective effects 
[5–11]. In particular, the results of our recent stud-
ies revealed that some of the active compounds isolated 
from Uncaria rhynchophylla (Gouteng) and Scutellaria 
baicalensis (Huangqin), which are two of the key herbs 
used in TGY, promoted the clearance of pathogenic pro-
teins and suppressed the progression of PD [5, 6, 10].
Although the clinical and pharmacological evalua-
tion of TGY and its component herbs have been attract-
ing interest in relevant fields, the quality analysis of 
TGY remains unsatisfactory. TGY consists of 11 herbs, 
including Gastrodia elata (Tianma), U. rhynchophylla 
(Gouteng), Cyathula officinalis (Chuan Niu Xi), Gardenia 
jasminoides (Zhizi), S. baicalensis (Huangqin), Eucommia 
ulmoides (Du Zhong), Leonurus japonicus (Yimucao), 
Taxillus chinensis (Sang Ji Sheng), Polygonum multiflorum 
(Ye Jiao Teng), Poria cocos (Fuling) and Haliotis diversi-
color (Shi Jue Ming) [1]. TGY contains a complex mix-
ture of chemical ingredients, including numerous small 
molecules (e.g., glycosides, quinic acids, terpenes and 
flavonoids) and a large amount of carbohydrates (e.g., 
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monosaccharides, oligosaccharides and polysaccharides). 
The only small molecules listed as quality control mark-
ers for TGY in the Chinese Pharmacopeia are baicalin 
and gastrodin [1]. Several methods have been reported 
for the analysis of a few marker compounds in TGY, 
including geniposide, rhynchophylline and isorhyncho-
phylline by thin layer chromatography (TLC) and high 
performance liquid chromatography (HPLC) [13–15]. 
However, these methods found that the contents of these 
markers were only 2.05 %, suggesting that a large number 
of the compounds in TGY were being left undetermined. 
As a product of decoction, TGY also contains several 
other constituents such as macromolecules, including a 
large amount of carbohydrates (e.g., monosaccharides, 
oligosaccharides and polysaccharides) [16]. However, the 
analytical methods published to date for the analysis of 
TGY have missed this critical part. The existing analytical 
methods for the quality control of TGY are therefore not 
suitable to deliver consistent quality control.
The aim of this study was to develop a quantitative 
analytical method for evaluating the chemical profiles 
of ten commercial TGY samples and one sample pro-
duced in our laboratory. Ultra-high performance liquid 
chromatography (UHPLC) coupled with quadrupole-
tandem time-of-flight mass spectrometry (Q-TOF-MS) 
was used to analyze 17 non-saccharide compounds, and 
high performance liquid chromatography coupled with 
an evaporative light scattering detector (HPLC-ELSD) 
was used to quantitatively determine three major sac-
charides. The macromolecular contents of these samples 
(i.e., polysaccharides, proteins and nucleic acids) were 




Acetonitrile (MS grade) was purchased from RCI Lab 
scan Ltd (Bangkok, Thailand). Analytical grade formic 
acid was purchased from Sigma-Aldrich (St. Louis, MO, 
USA). HPLC grade methanol and ethanol were obtained 
from Merck (Darmstadt, Germany). Deionized water was 
prepared using a Millipore MilliQ-Plus water purification 
system (Millipore, Bedford, MA, USA).
Reference standards of l-phenylalanine (1), catechin 
(2), genipin-1-gentiobioside (3), epicatechin (4), geni-
poside (5), leonurine (6), 2,3,5,4′-tetrahydroxystilbene-
2-O-β-d-glucoside (7), cyasteron (8), corynoxeine (9), 
isorhynchophylline (10), isocorynoxeine (11), baicalin 
(12), rhynchophylline (13), oroxylinA-7-O-glucuronide 
(14), bacalein-6-O-beta-glucopyranoside (15), wogon-
oside (16) and wogonin (17) were purchased from 
Chengdu Preferred Biotechnology Co., Ltd (Chengdu, 
China). The identities of the reference standards were 
confirmed by mass spectrometry prior to being used. The 
purities of the reference standards were determined to be 
greater than 98 % by UPLC-DAD analysis based on peak 
area normalization. Reference standards of fructose, glu-
cose and sucrose were purchased from Sigma-Aldrich. 
The structures of the reference standards are shown in 
Fig. 1.
Commercial samples (TGY1–10) were purchased 
from different pharmacies in several different regions 
of China, including Jilin, Beijing, Nanchang, Shenzhen 
and Hong Kong. The sample designated TGY11 evalu-
ated in the current study was prepared in our labora-
tory using herbal materials purchased from the Mr & 
Mrs Chan Hon Yin Chinese Medicine Specialty Clinic 
and Good Clinical Practice Centre, Hong Kong Baptist 
University, China. All of the herbs used in the current 
study were identified and authenticated by Professor 
Zhong-Zhen Zhao from the School of Chinese Medi-
cine, Hong Kong Baptist University, China. Voucher 
specimens were deposited at the School of Chi-
nese Medicine, Hong Kong Baptist University, Hong 
Kong, China (Collection numbers A110607, 110991, 
A1202151, 1300942, A121017, 131110, 140102, 140112, 
130906, 130603).
Sample solutions preparation
The commercial samples (TGY1–10) were ground into 
fine powders and passed through a 60–80 mesh filter. A 
small accurately weighed sample (20  mg) of each pow-
der was then dissolved in distilled water in a 10 mL volu-
metric flask at room temperature. All of the resulting 
sample solutions were filtered through a 0.22 µm nylon-
membrane filter (Millipore, Barcelona, Spain) prior to 
being analyzed to determine the 17 non-saccharide small 
molecules.
The TGY11 material prepared in our laboratory con-
sisted of the following materials: G. elata (Tianma) (9 g), 
U. rhynchophylla (Gouteng) (12 g), C. officinalis (Chuan 
Niu Xi) (18 g), G. jasminoides (Zhizi) (9 g), S. baicalensis 
(Huangqin) (9  g), C. officinalis (Chuan Niu Xi) (9  g), E. 
ulmoides (Du Zhong) (9 g), L. japonicus (Yimucao) (9 g), 
T. chinensis (Sang Ji Sheng) (9 g), P. multiflorum (Ye Jiao 
Teng) (9 g) and P. cocos (Fuling) (9 g) [1]. All of the crude 
materials were powdered and extracted three times by 
refluxing in boiling water (1:10, w/v) for 1  h. The com-
bined extracts were then filtered and evaporated under 
reduced pressure, before being freeze-dried to give the 
TGY11 material as a powder. This powders were then 
prepared according to the procedure described above for 
the preparation of the commercial samples.
For the analysis of the saccharides, a small accurately 
weighed portion (10  mg) of each sample was dissolved 
in 2 mL of water. Ethanol (8 mL) was then added slowly 
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added to each aqueous solution to precipitate any macro-
molecular components. The resulting mixtures were held 
for 24  h at room temperature, before being centrifuged 
on a 5804 Eppendorf multi-purpose centrifuge (Eppen-
dorf Bio Tools, Radnor, PA, USA) at 3250×g for 15 min. 
The supernatant was collected and evaporated to dry-
ness to give a residue, which was dissolved in a 1:1 (v/v) 
mixture of ACN and water (1  mL) and filtered through 
a 0.22 nylon-membrane filter (Millipore). The result-
ing filtrates were subjected to HPLC-ELSD analysis to 
determine their fructose, glucose and sucrose levels. The 
precipitate from the centrifugation step was dried and 
weighed to determine the macromolecular content of 
each sample [17].
Fig. 1 Chemical structures of the positively identified constituents of the TGY decoction
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Standard solutions preparation
Reference standards of l-phenylalanine, catechin, geni-
pin-1-gentiobioside, epicatechin, geniposide, leonurine, 
2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside, cyas-
teron, corynoxeine, isorhynchophylline, isocorynoxeine, 
rhynchophylline, baicalin, oroxylinA-7-O-glucuronide, 
wogonoside, baicalein and wogonin were weighed and 
dissolved in different volumes of methanol containing 
distilled water to prepare stock solutions. Samples of 
these stock solutions were then mixed together to pre-
pare a mixed standard solution. The standard saccha-
ride solutions were prepared according to the methods 
described in our previous publication [18]. Reference 
markers of fructose, glucose and sucrose were accurately 
weighed and dissolved in a 1:1 (v/v) mixture of ACN and 
water. Calibration curves were obtained by the appropri-
ate dilution of these mixed standard solutions.
Analytical methods
Chromatographic analysis was performed on an Agilent 
1290 UHPLC system (Agilent Technologies, Santa Clara, 
CA, USA) equipped with a binary pump, a thermostat-
controlled column compartment, an auto sampler and 
a DAD detector. Separations were conducted over an 
Acquity UPLC BEH C18 column (2.1 × 100 mm, 1.7 µm, 
Waters, Milford, CT, USA) at 40 °C with a gradient elu-
tion consisting of 0.1  % formic acid in water (mobile 
phase A) and 0.1  % formic acid in ACN (mobile phase 
B). The column was eluted with the following gradient 
program: 0–3 min, 2 % B; 3–9 min, 2–12 % B; 9–24 min, 
12–32  % B; 24–29  min, 32–75  % B; 29–29.1  min, 
75–100 % B; 29.1–32 min, 100 % B. The flow rate was set 
at 0.4 mL/min.
An Agilent 6540 Q-TOF mass spectrometer (Agilent 
Technologies) equipped with a jet stream electrospray 
ionization (ESI) source was used to acquire the MS and 
MS/MS data in the positive and negative ionization 
modes. Data acquisition was controlled using Mass-
HunterB.03 software (Agilent Technologies, Wilming-
ton, USA). The operating parameters were set as follows: 
nebulizing gas (N2) flow rate, 8.0  L/min; nebulizing gas 
temperature, 300 °C; jet stream gas flow, 9 L/min; sheath 
gas temperature, 350  °C; nebulizer gas pressure, 45 psi; 
capillary voltages, 3000  V; skimmer voltage, 65  V; Oct 
RFV, 600 V; fragment voltage, 150 V. Mass spectra were 
recorded for m/z values in the range of 100–1700 with 
accurate mass measurements for all of the mass ions. 
The peak areas determined in the extracted ion chroma-
tograms were placed into calibration curves, which were 
prepared by plotting the peak areas of samples containing 
different concentrations to calculate the non-saccharide 
small molecule contents contained in this decoction.
The HPLC-ELSD conditions used for the determina-
tion of the saccharides were described in our previous 
publication [18]. An Agilent 1100 liquid chromatograph 
system (Agilent Technologies, Palo Alto, CA, USA) 
equipped with an Alltech 2000 evaporative light-scatter-
ing detector (Grace, Deerfield, MA, USA) was used. The 
chromatographic separations were performed over an 
Asahipak NH2P-50 4E column (4.6 × 250 mm, Shodex, 
Tokyo, Japan) at a column temperature of 30 °C. The col-
umn was eluted with a mixture of water (mobile phase A) 
and ACN (mobile phase B) at a flow rate of 0.8 mL/min. 
The elution conditions were as follows: 0–16 min, 78 % B; 
16–20 min, 78–62 % B; 20–30 min, 62–60 % B. The drift 
tube temperature of the ELSD was set at 120 °C, and the 
nitrogen flow rate was set at 3.2 L/min. The peak areas in 
the ELSD chromatograms were collected to calculate the 
concentrations of the different components. Calibration 
curves were generated by plotting the logarithmic values 
of the different peak areas against the logarithmic values 
of the corresponding concentrations.
Method validation
The optimum method for the quantitative analysis of 
the samples was validated in terms of its linearity, sen-
sitivity, precision, accuracy and stability. Stock solutions 
of the mixed standards were diluted to a variety of dif-
ferent concentrations to allow for the construction of 
calibration curves. At least six concentrations of each 
reference standard were analyzed in triplicate. The cali-
bration curves were constructed by plotting the peak 
areas versus the concentrations of the corresponding 
constituents. The limit of detection (LOD) and limit of 
quantification (LOQ) values for the optimum conditions 
were determined at signal-to-noise ratios (S/N) of 3 and 
10, respectively. The intra- and inter-day variations were 
used to evaluate the precision of our newly developed 
method. Six independently prepared solutions of TGY11 
were analyzed within 1 day to evaluate the intra-day vari-
ability of the optimum method. To evaluate the inter-
day variability of this method, we examined the same 
sample twice a day over 3 consecutive days. Variations 
were expressed as relative standard deviations (RSDs) of 
the data, which were calculated using the following for-
mula: RSD (%) = (standard deviation/mean) × 100%. A 
recovery test was performed to evaluate the accuracy of 
the optimum method by adding three different concen-
trations of a standard solution (i.e., low, medium and 
high) to TGY11, which contained known quantities of the 
target compounds. These samples were then analyzed in 
parallel using our newly established method. Each exper-
iment was conducted in triplicate at each level. The spike 
recoveries were calculated using the following equation:
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The stability of the optimal method was evaluated by 
analyzing the TGY11 extracts over periods of 0, 2, 4, 8, 12 
and 24 h. The RSDs of the peak areas of each compound 
were used as an indication of the stability.
Results and discussion
Optimization of the chromatographic conditions
The MS experiments were performed on an LC–MS sys-
tem equipped with an ESI source to optimize the reso-
lution, sensitivity and analytical time of this method. 
A full MS scan was obtained in the form of a total ion 
chromatogram (TIC). With regard to MS conditions, all 
of the samples were simultaneously evaluated in the posi-
tive and negative ionization modes. The positive ioniza-
tion mode provided much more ESI information than 
the negative ionization mode and was therefore selected 
for the subsequent experiments. The gradient elution 
program was also optimized eluting with 0.1  % formic 
acid in water (mobile phase A) and 0.1 % formic acid in 
ACN (mobile phase B) under the following conditions: 
0–3 min, 2 % B; 3–9 min, 2–12 % B; 9–24 min, 12–32 % 
B; 24–29  min, 32–75  % B; 29–29.1  min, 75–100  % B; 
29.1–32  min, 100  % B. These conditions provided the 
best separation and peak shapes for all of compounds 
evaluated in the current study. Formic acid was added to 
the mobile phase to give a final concentration of 0.1 % to 
allow for the complete ionization of TGY. Representative 
chromatograms of the reference standards and TGY sam-
ples are shown in Fig. 2.
Identification of chemical compounds
The peaks observed in the chromatograms of the TGY 
samples were primarily identified based on a comparison 
of their accurate molecular mass data with those of the 
reference standards and data from the literature [19–23]. 
In this way, we were able to identify 28 compounds. Data 
for the MS/MS fragments of the different peaks were also 
obtained and these results are summarized in Table  1. 
Representative TICs of TGY in the positive ionization 
mode are shown in Fig. 2a. Chromatograms of the mono- 
and oligosaccharides found in the different TGY samples 
were obtained by HPLC-ELSD for the analysis of the sac-
charides, and the results are shown in Fig. 3. Three peaks 
were identified following this analysis, including fructose, 
glucose and sucrose by comparing their retention times 
with those of the reference standards.
A comparison of the retention time and MS/MS frag-
mentation data for the TGY samples with those of the 
reference standards led to the successful identification 
of 17 non-saccharide compounds. Specifically, peaks 
Spike recovery (%) = (total amount detected− amount original)
/amount spiked × 100%
1–17 were unambiguously identified as l-phenylala-
nine, catechin, genipin-1-gentiobioside, epicatechin, 
geniposide, leonurine, 2,3,5,4′-tetrahydroxystilbene-2-
O-β-d-glucoside, cyasteron, corynoxeine, isorhyncho-
phylline, isocorynoxeine, rhynchophylline, baicalin, 
oroxylinA-7-O-glucuronide, wogonoside, baicalein and 
wogonin, respectively. The chemical structures of these 
compounds are shown in Fig. 1.
Based on a comparison with data from the litera-
ture, peaks 18–25 were tentatively attributed to vanillin, 





Peak 18 was determined to be vanillin based on its 
mass spectrum, which contained a molecular ion peak 
with an m/z value of 153.0546 for [M+Na]+ [24]. The 
mass spectrum for peak 19 contained a molecular ion 
peak with an m/z value of 705.2367 for [M+Na]+, which 
corresponded well with pinoresinol diglucoside [20, 25]. 
The mass spectra of peaks 20 and 21 contained molecu-
lar ion peaks with m/z values of 549.1646 and 549.1620, 
respectively, for [M+H]+. These peaks could be attrib-
uted to chrysin-6-C-ara-8-C-glu or chrysin-6-C-glu-8-
C-ara. Although the MS/MS fragmentation spectra of 
these peaks contained identical signals with m/z values 
of 489, 459 and 429, the intensities of these ions varied 
considerably for the different peaks. Data from the lit-
erature suggested that chrysin-6-C-ara-8-C-glu would 
have a shorter retention time than chrysin-6-C-glu-8-C-
ara. Based on this information, peak 20 was tentatively 
attributed to chrysin-6-C-ara-8-C-glu, whereas peak 21 
was attributed to chrysin-6-C-glu-8-C-ara [21, 26]. Peak 
22 was attributed to quercitrin based on a comparison 
of its MS and MS/MS fragmentation spectra with those 
reported in the literature [20]. It is noteworthy that the 
mass spectrum for quercitrin contained a molecular ion 
with an m/z value of 449.1178 for [M+H]+, whereas the 
MS/MS fragmentation spectrum contained a peak with 
an m/z value of 303.0486. This new peak was attributed 
to the formation of a quercetin aglycone fragment fol-
lowing the loss of a fragment with a molecular weight of 
176. The ESI analysis of peak 23 in the positive ionization 
mode gave a molecular ion with an m/z value of 447.0922 
for [M+H]+, along with a fragment ion with an m/z value 
of 271.0617 for the aglycone cation. Based on these data, 
peak 23 was tentatively identified as norwogonin-7-O-
glucuronide [27]. Peaks 24 and 25 were attributed to iso-
meric compounds and eluted with retention times of 18.9 
and 19.8 min, respectively. Furthermore, these peaks gave 
molecular ions with m/z values of 477.1065 and 447.1058, 
respectively. The MS/MS fragmentation spectra of these 
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Fig. 2 Typical UPLC‑Q‑TOF chromatograms. Reference standards (a); blank solvent (b); self‑made sample TGY11 (c); Commercial samples TGY1  
(d) and TGY6 (e)
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peaks both produced an ion with an m/z value 301. The 
loss of a fragment with a molecular weight of 176 in the 
MS/MS fragmentation spectrum was consistent with 
the presence of a glucuronide group. Peaks 24 and 25 
were therefore tentatively attributed to 5,7,8-trihydroxy-
6-methoxyflavone-7-glucuronide and 5,6,7-trihydroxy-
8-methoxyflavone-7-glucuronide, respectively, based on 
their accurate mass and MS/MS fragmentation data [27].
Method validation
Linearity calibration curves were constructed using at 
least six different concentrations of the reference stand-
ards. Each concentration of the reference standards was 
analyzed in duplicate. The results revealed that there was 
a good correlation between the concentration and peak 
area of these compounds, as indicated by the high coef-
ficients of determination (r2  >  0.999). The linear ranges 
of the 17 different compounds evaluated in this way are 
summarized in Table 2. The LOD and LOQ values were 
measured using signal to noise ratios of 3:1 and 10:1, 
respectively, and the results are also listed in Table 2. A 
solution of the TGY11 material prepared in our labora-
tory was analyzed six times within 24 h under the opti-
mized conditions to evaluate the intra-day variation of 
the method. The same solution was also analyzed on 3 
successive days to assess the inter-day variation of the 
optimized method, as well as its precision and accuracy. 
The RSDs of the intra- and inter-day variations were 
4.06 and 5.54  %, respectively, which indicated that our 
newly established method had satisfactory precision and 
repeatability properties. The results of spiking recovery 
experiments showed that our newly developed method 
performed well with a mean recovery in the range of 
94.37–105.99 with RSDs of less than 4.5  % for the 17 
positively identified compounds. The stability of our 
newly developed method was determined by assessing 
the RSDs of the peaks of the 17 positively identified com-
pounds within 24 h. The results of this analysis revealed 
that the RSDs of all 17 compounds were less than 4.6 %. 
Taken together, these results demonstrated that our 
newly developed UPLC-Q-TOF method was sufficiently 
reliable and accurate for the simultaneous quantification 
Fig. 3 Typical HPLC‑ELSD chromatograms. TGY sample (TGY11) (A); reference standards (B) (a: fructose, b: glucose, c: sucrose)
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of the 17 positively identified non-saccharide compounds 
in TGY.
Quantification of compounds in commercial samples
Our newly developed UPLC-Q-TOF and HPLC-ELSD 
methods were successfully applied to the simultaneous 
determination of 20 identified compounds in 10 com-
mercial TGY samples (TGY1–10) and one lab-prepared 
sample (TGY11). The results of these analyses are sum-
marized in Table 3 and Fig. 4. The 17 positively identified 
non-saccharide compounds accounted for 0.5–6.1  % of 
the overall weight of the TGY samples, whereas the three 
mono- and di-saccharides accounted for 7–14.2  %. The 
biggest contribution to the weight of the TGY samples 
came from macromolecules, which account for 30–70 % 
of the total weight. The quantification percentage of the 
commercial TGY samples reached up to 78.33 %, thereby 
demonstrating the suitability of our newly developed 
method for the quality control of TGY samples in terms 
of accounting for most of the major components.
All 17 of the positively identified non-saccharide com-
pounds were found in the lab-prepared sample (TGY11), 
with baicalin being the most abundant. The contents of 
these compounds varied considerably in the samples 
collected from the different manufacturers. For exam-
ple, rhynchophylline, isorhynchophylline, corynox-
eine and isocorynoxeine are considered to be the four 
main bioactive constituents of U. rhynchophylla [6, 13, 
28]. However, the amount of corynoxeine detected in 
TGY6 was six times greater than that detected in TGY9. 
Furthermore, none of these four alkaloids were detected 
in TGY1–5. This result implied that there were inconsist-
encies in the quality of the TGY decoctions. These varia-
tions in the quality could be attributed to various factors, 
including differences in the origins of the plants, as well 
as differences in the planting methods, harvest time, 
geographical climate and processing methods. The fruc-
tose, glucose and sucrose contents of the samples also 
fluctuated considerably between the different samples. 
Once again, these variations could be attributed in part 
to differences in the pretreatment processes or manu-
facturing procedures. It is noteworthy that much larger 
amounts of sucrose were found in TGY1–5 than any of 
the other samples. In terms of the macromolecular con-
tents of these samples, the contents of TGY8 and TGY11 
were 696.64 and 294.98 mg/g, respectively. This variation 
may have been introduced as a consequence of the dif-
ference in the raw materials, extraction process or pro-
cessing procedures. Also, the presence of excipients in 
the sample matrix could have a significant impact on the 
contents of the sample being investigated.
Compared with other methods reported in the litera-
ture [1, 13–15, 29], which have been used to determine 
the total contents of only a few chemical markers at con-
centrations as low as 2.05 %, the method described herein 
was used to quantify almost 60–80 % of the compounds 
found in TGY, representing a clear majority. The percent-
age ratios of the components determined in the current 
study are shown in Fig.  4. These results show that the 
quantification percentages of the commercial samples 
Fig. 4 Content percentages of the chemicals determined in this study
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could reach up to 78.33  %, whereas that of TGY11 was 
much lower at 50  %. Notably, more than 40  % of the 
chemicals present in TGY11 remained unidentified. 
These chemicals could include amino acids, inorganic 
salts or some other ingredients. However, it is also possi-
ble that the addition of 80 % ethanol was not sufficient to 
precipitate all of the polysaccharides completely, and that 
those with lower molecular weights remained in solution 
[17] and their content could not be determined.
Conclusions
The developed UHPLC/Q-TOF-MS and HPLC-ELSD 
methods successfully identified 28 of the complex com-
pounds found in TGY, and quantified 20 of them.
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